Home/Filings/4/0001209191-19-044012
4//SEC Filing

Spada Alfred P. 4

Accession 0001209191-19-044012

CIK 0001383701other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:13 PM ET

Size

26.2 KB

Accession

0001209191-19-044012

Insider Transaction Report

Form 4
Period: 2019-08-01
Spada Alfred P.
SVP, R&D and CSO
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-01100,6250 total
    Exercise: $4.21Exp: 2027-01-25Common Stock (100,625 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-01175,0000 total
    Exercise: $2.00Exp: 2029-02-06Common Stock (175,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-0121,8750 total
    Exercise: $1.85Exp: 2026-02-03Common Stock (21,875 underlying)
  • Award

    Restricted Stock Units

    2019-08-01+313,436313,436 total
    Common Stock (313,436 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-0150,0000 total
    Exercise: $9.45Exp: 2024-02-06Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-01109,3750 total
    Exercise: $1.85Exp: 2026-02-03Common Stock (109,375 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-0170,0000 total
    Exercise: $5.17Exp: 2028-02-03Common Stock (70,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-08-01100,0000 total
    Exercise: $6.40Exp: 2025-02-22Common Stock (100,000 underlying)
Footnotes (15)
  • [F1]Immediately exercisable.
  • [F10]On August 1, 2019, the Issuer canceled the option granted on February 4, 2018. In exchange for the canceled option, the Reporting Person received 35,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F11]The option was granted on February 7, 2019. 25% of the total number of shares of common stock subject to the option will vest on February 7, 2020, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • [F12]On August 1, 2019, the Issuer canceled the option granted on February 7, 2019. In exchange for the canceled option, the Reporting Person received 87,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F13]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F14]Represents 25,000 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 7, 2014; 50,000 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 23, 2015; 54,687 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 4, 2016; 10,937 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 4, 2016; 50,312 restricted stock units received in exchange for canceling the Reporting Person's option granted on January 26, 2017; 35,000 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 4, 2018; and 87,500 restricted stock units received in exchange for canceling the Reporting Person's option granted on February 7, 2019.
  • [F15]The restricted stock units will vest, subject to the Reporting Person's continuous service to the Issuer through the vesting date, on the first anniversary of the grant date. In addition, the restricted stock units will vest upon a Change of Control, an employee's termination without Cause, or resignation for Good Reason, as such terms are defined in the Issuer's 2013 Incentive Award Plan. Upon any other termination of service of the Reporting Person, unvested restricted stock units will be forfeited.
  • [F2]On August 1, 2019, the Issuer canceled the option granted on February 7, 2014. In exchange for the canceled option, the Reporting Person received 25,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]On August 1, 2019, the Issuer canceled the option granted on February 23, 2015. In exchange for the canceled option, the Reporting Person received 50,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The option was granted on February 4, 2016. 25% of the total number of shares of common stock subject to the option vested on February 4, 2017, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • [F5]On August 1, 2019, the Issuer canceled the option granted on February 4, 2016. In exchange for the canceled option, the Reporting Person received 54,687 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F6]On August 1, 2019, the Issuer canceled the option granted on February 4, 2016. In exchange for the canceled option, the Reporting Person received 10,937 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F7]The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option vested on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • [F8]On August 1, 2019, the Issuer canceled the option granted on January 26, 2017. In exchange for the canceled option, the Reporting Person received 50,312 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F9]The option was granted on February 4, 2018. 25% of the total number of shares of common stock subject to the option vested on February 2, 2019, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Issuer

Conatus Pharmaceuticals Inc.

CIK 0001383701

Entity typeother

Related Parties

1
  • filerCIK 0001580465

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:13 PM ET
Size
26.2 KB